Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
React to this article
Latest news
Date Title
02:28aDJAsian Markets Wobble on U.S. Drop, China Worries -- 2nd Update
02:27a EVERGREEN MARINE : Names Final L-Type Vessel Aug-28-2015
02:27a CHINA INFORMATION TECHNOLOGY DEVELOPMENT : Monthly Return of Equity Issuer on Movements in Securi...
02:27a DME DUBAI MERCANTILE EXCHANGE : Oman Tank Terminal Company (OTTCO) Launches Floating Storage Facility in Oman
02:27a WM MORRISON SUPERMARKETS : *jpmorgan cuts morrison price target to 200 (225) pence - 'neutral'
02:26a ARM : *jpmorgan raises arm to 'neutral' ('underweight') - price target 850 pence
02:26a TESCO : *nomura cuts tesco price target to 210 (220) pence - 'neutral'
02:25a DIPLOMA : Says Revenue Growth Held Back And Operating Margin Suffering
02:25a AGGREKO : Snaps Up Canadian Mobile Temperature Control Firm ICS
02:24a CATELLA A : EUR 850 million invested in sustainable real estate funds in Europe by mid-2016
Latest news
Advertisement
Hot News 
AGA RANGEMASTER : shares heat up over rival bid from Whirlpool
PATRICK : Elkhart's Patrick Industries acquires Michigan-based North American Forest Products in $85M deal
SUPER MICRO COMPUTER : Supermicro® Debuts Embedded Motherboard and System Solutions Supporting the New 6th Gen Intel® Core(TM) Processor Family
DOLLAR TREE : sales surge but Family Dollar costs weigh on earnings
WORLD WRESTLING ENTERTAINMENT : Man shot by deputy outside WWE building remains critical at ORMC
Most Read News
09/01 Women's Advocate-Paralympian-Actress Aimee Mullins Joins Legendary Voice Builder Gary Catona To Help Women Worldwide Raise Their Voices For Gender Equality With MY VOICE MATTERS
09/01 COMMODITIES : Winners, Losers
09/01 EIA ENERGY INFORMATION ADMINISTRATION : Effects of Removing Restrictions on U.S. Crude Oil Exports ›
09/01 Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against MaxPoint Interactive, Inc. (MXPT)
09/01 Intellectual Property Insurance Services Corporation (IPISC) to Provide Patent Troll Insurance to Members of the Association of National Advertisers (ANA)
Most recommended articles
02:16a ASHTEAD : says confident on outlook after first quarter profit rise
02:16aDJCompagnie de Saint-Gobain Acquisition
02:14a ASOS : Britain's ASOS founder steps down as CEO
02:10a EUR/GBP TECHNICAL ANALYSIS : Waiting for Selling Opportunity
01:55a Analysis - Forex reserves unwind could reverse bond supercycle